Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study
- PMID: 16286098
- DOI: 10.1016/j.urology.2005.05.007
Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE Study
Abstract
Objectives: To determine the prevalence, diagnostic patterns, and management of prostatitis, interstitial cystitis, and epididymitis (PIE) in Canadian urology outpatient practice.
Methods: Representative urologists were randomly selected from the Canadian and Quebec Urological Associations. Each patient identified with a PIE diagnosis during a typical 2-consecutive-week period during April 2004 to July 2004 was requested to complete a corresponding Chronic Prostatitis Symptom Index (CPSI), O'Leary-Sant Symptom Index (OSSI), or a Chronic Epididymitis Symptom Index (CESI). Each day the participant urologist completed an outpatient log and a detailed programmed chart review to transcribe demographics, investigations, and treatments associated with each PIE patient.
Results: Sixty-five urologists were invited to participate. Fifty-seven (88%) agreed, and 48 (74%) completed the audit. Of the 8712 patients seen in outpatient practice (average 182 per urologist), 2675 were female and 6037 male. Prostatitis was identified in 2.7% of the men (n = 166; mean age 50 years; mean duration 3.1 years; mean CPSI score 19.7), interstitial cystitis in 2.8% of patients (n = 242; 211 women [7.9%], 26 men [0.4%]; mean age 50.2 years, mean duration 4.5 years, mean OSSI score 11.8), and epididymitis in 0.9% of men (n = 57; mean age 41.1 years, mean duration 2.5 years, mean CESI score 15.5). There was wide variance in investigations and treatments.
Conclusions: This prospective audit indicates that prostatitis might not be as common as frequently believed and that interstitial cystitis is more common, and it represents the first estimate of the prevalence of epididymitis in urologic practice. The wide variance in investigations and treatments confirms the need for practice management guidelines.
Similar articles
-
Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index.J Urol. 2001 Mar;165(3):842-5. J Urol. 2001. PMID: 11176483
-
Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis.J Urol. 2006 Mar;175(3 Pt 1):963-6; discussion 967. doi: 10.1016/S0022-5347(05)00351-4. J Urol. 2006. PMID: 16469592
-
The patient with chronic epididymitis: characterization of an enigmatic syndrome.J Urol. 2002 Apr;167(4):1701-4. J Urol. 2002. PMID: 11912391
-
Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities.Urology. 2007 Apr;69(4 Suppl):60-3. doi: 10.1016/j.urology.2006.08.1106. Urology. 2007. PMID: 17462482 Review.
-
[Diagnosis of prostatitis in the light of current knowledge].Orv Hetil. 1989 May 14;130(20):1031-5. Orv Hetil. 1989. PMID: 2471951 Review. Hungarian.
Cited by
-
Cognitive Behavioral Therapy for Chronic Pelvic Pain: What Is It and Does It Work?J Urol. 2024 Apr;211(4):539-550. doi: 10.1097/JU.0000000000003847. Epub 2024 Jan 16. J Urol. 2024. PMID: 38228093 Review.
-
Chronic epididymitis due to Chlamydia trachomatis LGV-L2 in an HIV-negative heterosexual patient: a case report.Front Public Health. 2023 May 9;11:1129166. doi: 10.3389/fpubh.2023.1129166. eCollection 2023. Front Public Health. 2023. PMID: 37228719 Free PMC article.
-
Identification of hub genes and biological mechanisms underlying the pathogenesis of asthenozoospermia and chronic epididymitis.Front Genet. 2023 Apr 21;14:1110218. doi: 10.3389/fgene.2023.1110218. eCollection 2023. Front Genet. 2023. PMID: 37152990 Free PMC article.
-
Study protocol and methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a randomized clinical trial of brief, low-intensity, transdiagnostic cognitive behavioral therapy vs education/support for urologic chronic pelvic pain syndrome (UCPPS).Trials. 2022 Aug 13;23(1):651. doi: 10.1186/s13063-022-06554-9. Trials. 2022. PMID: 35964133 Free PMC article.
-
Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial.World J Urol. 2022 Oct;40(10):2505-2511. doi: 10.1007/s00345-022-04074-4. Epub 2022 Jul 8. World J Urol. 2022. PMID: 35802142 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous